Dancor - One Week off the Blister

被引：0
|
作者：
Wenzl, Astrid [1 ]
机构：
[1] Merck Gesell mbH Osterreich, Zimbagasse 5, A-1147 Vienna, Austria
来源：
JOURNAL FUR KARDIOLOGIE | 2012年 / 19卷 / 9-10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：306 / 306
页数：1
相关论文
共 50 条
  • [1] Dancor((R)) - One Week off the Blister
    Wenzl, Astrid
    JOURNAL FUR HYPERTONIE, 2012, 16 (04): : 41 - 41
  • [2] Dose Dense One Week On/One Week Off Temozolomide in Recurrent Glioma
    Taal, Walter
    Segers-Van Ryn, Joyce
    Kros, J. Max
    van der Rijt, Karin
    Bromberg, Jacoline
    Smitt, Peter Sillevis
    Bent, Martin
    NEUROLOGY, 2011, 76 (09) : A98 - A98
  • [3] One week on/one week off:: A novel active regimen of temozolomide for recurrent glioblastoma
    Wick, W
    Steinbach, JP
    Küker, WM
    Dichgans, J
    Bamberg, M
    Weller, M
    NEUROLOGY, 2004, 62 (11) : 2113 - 2115
  • [4] Dose-intensified rechallenge with temozolomide: One week on/one week off versus 3 weeks on/one week off in patients with progressive or recurrent glioblastoma (DIRECTOR).
    Tabatabai, Ghazaleh
    Wick, Wolfgang
    Reifenberger, Guido
    Steinbach, Joachim Peter
    Schnell, Oliver
    Hau, Peter
    Herrlinger, Ulrich
    Sabel, Michael
    Ketter, Ralf
    Schlegel, Uwe S.
    Marosi, Christine
    Goldbrunner, Roland
    Homicsko, Krisztian
    Nikkhah, Guido
    Pichler, Josef
    Vajkoczy, Peter
    Meixensberger, Juergen
    Weller, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] One week on/one week off regimen of temozolomide: Phase II trial in recurrent glioma
    Wick, W.
    Wick, A.
    Schuth, J.
    Platten, M.
    Reifenberger, G.
    Weller, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] One week on/one week off regimen of temozolomide for recurrent glioblastoma: A phase III study.
    Wick, W
    Steinbach, JP
    Schuth, J
    Dichgans, J
    Bamberg, M
    Weller, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 116S - 116S
  • [7] Dose-intensified rechallenge with temozolomide: One week on/one week of versus 3 weeks on/one week off in patients with progressive or recurrent glioblastoma
    Weller, M.
    Tabatabai, G.
    Reifenberger, G.
    Herrlinger, U.
    Pichler, J.
    Schnell, O.
    Wick, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Week on, week off
    Buckland, J
    NATURE REVIEWS IMMUNOLOGY, 2002, 2 (02) : 72 - 72
  • [9] Week on, week off
    Jenny Buckland
    Nature Reviews Immunology, 2002, 2 : 72 - 73
  • [10] “One week on–one week off”: efficacy and side effects of dose-intensified temozolomide chemotherapy: experiences of a single center
    Norbert Galldiks
    Theresa Berhorn
    Tobias Blau
    Veronika Dunkl
    Gereon R. Fink
    Michael Schroeter
    Journal of Neuro-Oncology, 2013, 112 : 209 - 215
12345